Simulated Populations Used To Probe Gene Mapping

More powerful computers are allowing scientists and engineers to conduct simulations that grow more realistic each year. While companies are using these tools to slash the costs of producing everything from airliners to antibiotics, researchers in Houston are using them to refine their search for the genetic causes of disease. In a new study published in the journal PLoS Genetics, statisticians and genetic epidemiologists from Rice University and The University of Texas M. D. Anderson Cancer Center used computer simulations to trace genetic changes over thousands of generations in a simulated population of hundreds of thousands of people. The goal: find out whether the tools that statistical geneticists use to pinpoint disease genes are up to the task of identifying multiple genes that cause complex diseases like cancer. "In a real population, you never have the complete genetic picture, particularly for complex diseases where more than one gene is implicated and where environmental factors play a role," said lead author Bo Peng of M. D. Anderson. "If we only see the people who get sick, we can never be sure how many people with the disease variant of the gene avoided getting sick. And there's always the question about how many people got the disease even though they didn't carry the variant."... Whole article: "www.sciencedaily.com":[ http://www.sciencedaily.com/releases/2007/03/070323171514.htm]

---

Related articles

How An Antibiotic Inhibits Bacterial Growth - Scientists have known that the drug linezolid -- the first new antibiotic to enter the marketplace in 30 years -- works by binding to ribosomes, the protein production factory of the cell "Linezolid targets ribosomes, inhibits protein synthesis, and kills bacteria," said Alexander Mankin, professor and associate director of UIC's Center for Pharmaceutical Biotechnology and lead investigator of the study Linezolid is a synthetic antibiotic used for the treatment of infections caused by pathogens such as staph and strep, including multi-drug-resistant bacteria Whole article ScienceDaily (14.5.2007)

Cheap molecule may attack tumors - A cheaply-produced molecule may be the key to treating a variety of cancers, claim Canadian researchers Dicholoroacetate (DCA) has been suggested for years as a possible treatment for certain rare metabolic disorders in children The University of Alberta team, writing in the journal Cancer Cell, now say it could encourage cancer cells to die Experts say much more research will be needed before an effective cancer treatment can emerge Whole article onnews (23.4.2007)

Genes Associated With Adverse Reactions To Cancer Radiotherapy Treatment Identified - Medical scientists at the University of Leicester have announced a potentially unique advance in breast cancer research by identifying two genes associated with adverse reaction to cancer treatment The research could mean people who might react badly to radiotherapy could be warned in advance or alternative treatments be sought The team who carried out the study included Drs Paul Symonds, Mark Plumb, Irene Peat and George Giotopoulos of the Department of Cancer Studies and Molecular Medicine and the Department of Genetics at the University of Leicester Whole article on ScienceDaily (21.4.2007)

Resistance Is Futile - Antibiotics have saved countless lives since Alexander Fleming discovered penicillin in 1927 The new compounds evolved out of the discovery more than 30 years ago that deleting certain genes in bacteria prevents the microbes from evolving resistance when exposed to antibiotics read more on sciencenow (31.3.2007)

MicroRNA Helps Prevent Tumors - MicroRNAs are tiny snippets of RNA that can repress activity of a gene by targeting the gene's messenger RNA (which copies DNA information and starts the process of protein production) The first microRNA was discovered in 1993, in worms But given the wealth of microRNAs, and the ability of individual microRNAs to target hundreds of genes, researchers have struggled to show the biological impact of a particular microRNA on a particular target in mammals (although such connections have been shown in plants, worms and flies) Looking to find a promising target for an individual microRNA, Christine Mayr, a postdoctoral researcher in the Bartel lab, picked Hmga2, a gene that is defective in a wide range of tumors In these tumors, the protein-producing part of the Hmga2 gene is cut short and replaced with DNA from another chromosome Whole article: www (28.2.2007)